Can We Prevent C diff infection relapses with Vancomycin Prophlyaxis?

Can We Prevent C diff infection relapses with Vancomycin Prophlyaxis?

Journal Club is an engaging and interactive web-based journal club for Pharmacists, Preceptors, Student Pharmacists on advanced pharmacy practice experiences (APPEs), and Pharmacy Residents.

Clostridiodes difficile infections are a significant burden to patients and the healthcare community. Novel approaches are being investigated to help mitigate relapses. This application-based continuing pharmacy education will review recent infectious disease literature with a unique spin. Join us to learn how machine based learning can inform clinical trials and the recent updates on C diff infections.

Upon successful completion of this application-based course, pharmacists and students should be able to:
1. Define the risks for Clostridiodes difficile infection relapse
2. Discuss the evidence in the guidelines for prevention of Clostridiodes difficile infection relapse
3. Discuss the results and conclusions of clinical trial
4. Define machine based learning and the relevance to clinical trial evaluation
5. Analyze the use of machine based learning within clinical trials

Aaron Burton, PharmD, BCPS
Assistant Professor
School of Pharmacy and Physician Assistant Studies
University of Saint Joseph

Dr. Burton does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course. 

CEimpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read:

Caroff D, Menchaca B, Zhang Z, et al. Oral Vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses. Infection Control & Hospital Epidemiology 2019 40, 662-667.

*CEimpact provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Initial Release Date: September 9, 2020
Planned Expiration Date: September 9, 2023

Universal Activity Number (UAN): 0107-0000-20-249-H01-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information

Duration

1h 0m

Topic Designator

Disease State/Drug Therapy

ACPE

Yes

ACPE Topic

01 Drug Therapy

Role

Pharmacist

Media-Type

On-Demand

Release Date

9/10/20

CEUs

0.1

Rating

4

ACPE Number

0107-0000-20-249-H01-P

This course is in our subscription.

0